Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -76.66% is 59% above its 5-year average of -186.36%, near the high end of its 5-year range (-613.21%–-50.69%).
35.29% above its 12-month average of -118.46%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -62.69%.
OPERATING MARGIN
-76.66%
OPERATING MARGIN AVG TTM
-118.46%
OPERATING MARGIN AVG 3Y
-96.55%
OPERATING MARGIN AVG 5Y
-186.36%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+35.29%
CURRENT VS 3Y AVG
+20.60%
CURRENT VS 5Y AVG
+58.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lifeward Ltd.
Market Cap
$10.52M
Operating Margin
-76.66%
TTM Avg
-118.46%
3Y Avg
-96.55%
5Y Avg
-186.36%
Market Cap
$10.41M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$10.60M
Operating Margin
0.00%
TTM Avg
-390.79%
3Y Avg
-392.52%
5Y Avg
-325.49%
Market Cap
$10.59M
Operating Margin
-2455.91%
TTM Avg
-2057.20%
3Y Avg
-5101.18%
5Y Avg
-6363.25%
Market Cap
$10.30M
Operating Margin
-289668.18%
TTM Avg
-144834.09%
3Y Avg
-74061.36%
5Y Avg
-50713.07%
Market Cap
$10.65M
Operating Margin
-10711.18%
TTM Avg
-6476.04%
3Y Avg
-3238.02%
5Y Avg
-2158.68%
Market Cap
$10.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.74M
Operating Margin
-293.46%
TTM Avg
-272.89%
3Y Avg
-2404.23%
5Y Avg
-2129.99%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifeward Ltd. (LFWD) | $10.52M | -76.66% | -118.46% | -96.55% | -186.36% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -2960.13% | -1713.73% | -1142.49% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.60M | 0.00% | -390.79% | -392.52% | -325.49% |
| Pluri Inc. (PLUR)vs › | $10.59M | -2455.91% | -2057.20% | -5101.18% | -6363.25% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.30M | -289668.18% | -144834.09% | -74061.36% | -50713.07% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | -10711.18% | -6476.04% | -3238.02% | -2158.68% |
| Polyrizon Ltd. (PLRZ)vs › | $10.58M | N/A | 0.00% | 0.00% | 0.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -293.46% | -272.89% | -2404.23% | -2129.99% |
| Valion Bio, Inc. (VBIO)vs › | $10.25M | 0.00% | 0.00% | -312.48% | -347.37% |
Gross Margin
36.0%
Operating Margin
-76.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -62.69% |
| 2026-03-31 | -263.55% |
| 2025-12-31 | -100.73% |
| 2025-09-30 | -50.69% |
| 2025-06-30 | -114.66% |
| 2025-03-31 | -96.40% |
| 2024-12-31 | -126.27% |
| 2024-09-30 | -51.80% |
| 2024-06-30 | -66.24% |
| 2024-03-31 | -123.07% |
| 2023-12-31 | -89.15% |
| 2023-09-30 | -180.38% |
| 2023-06-30 | -385.79% |
| 2023-03-31 | -355.69% |
| 2022-12-31 | -229.69% |
| 2022-09-30 | -613.21% |
| 2022-06-30 | -278.73% |
| 2022-03-31 | -489.50% |
| 2021-12-31 | -308.45% |
| 2021-09-30 | -134.99% |
| 2021-06-30 | -218.73% |
